Document Detail

Treating survivors of the World Trade Center terrorist attacks of September 11, 2001.
MedLine Citation:
PMID:  15094698     Owner:  NLM     Status:  PubMed-not-MEDLINE    
As part of an established traumatic stress research and treatment program located in New York City, we experienced the September 11, 2001, terrorist attacks on the World Trade Center first as New Yorkers, but also as professionals with an interest in both treating the survivors and furthering scientific knowledge regarding the neurobiology and treatment of traumatic stress. This paper gives vignettes of calls to our program and the treatment of World Trade Center terrorist attack survivors.
Robert Grossman; Rachel Yehuda
Related Documents :
10225498 - Alcohol and the marriage effect.
8368918 - Violence and sexual violence in pornography: is it really increasing?
18077308 - 'no-contact' interventions for unhealthy college drinking:efficacy of alternatives to p...
24297498 - Cardiovascular applications of therapeutic ultrasound.
8816118 - Reliability and validity of the addiction severity index among homeless substance misus...
24942558 - Monkey alcohol tissue research resource: banking tissues for alcohol research.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  CNS spectrums     Volume:  7     ISSN:  1092-8529     ISO Abbreviation:  CNS Spectr     Publication Date:  2002 Aug 
Date Detail:
Created Date:  2004-04-19     Completed Date:  2005-04-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9702877     Medline TA:  CNS Spectr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  611-5     Citation Subset:  -    
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The medical student experience with disasters and disaster response.
Next Document:  Risk factors for liver fibrosis progression in patients with chronic hepatitis C.